Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...
But how exactly do weight loss drugs really work for individual women ... What’s more: Jordan is spreading her ...
The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in ...
New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback